SCHEMBL1007620

SCHEMBL1007620

Cc1cc(C)c(C2NC(=C3CCCCC3P(C3CCCCC3)C3CCCCC3)NC2c2c(C)cc(C)cc2C)c(C)c1.Cl[Ru](Cl)=Cc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246487 0.80
SCHEMBL3391334 0.71 POLB (0.35)
SCHEMBL539282 0.71 POLB (0.35)
SCHEMBL1831745 0.70
SCHEMBL19207343 0.68
SCHEMBL29534779 0.64 TSHR (0.33)
SCHEMBL14974857 0.63
SCHEMBL29489277 0.62 TAS1R3 (0.31)
SCHEMBL5198091 0.61
SCHEMBL4608209 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012097078-A2 VISCOSUPPLEMENTARY MATERIALS FLEX BIOMEDICAL (US) 2012-07-19 WO disclosed
EP-2280935-A1 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2011-02-09 EP disclosed
EP-2268606-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-01-05 EP disclosed
WO-2009132979-A1 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-11-05 WO disclosed
WO-2009132978-A1 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-11-05 WO disclosed